| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability described as problematic has been identified in Cybozu Garoon. Impacted is an unknown function. The manipulation results in path traversal. This vulnerability is identified as CVE-2014-0820. There is not any exploit available.
Details
A vulnerability classified as problematic has been found in Cybozu Garoon (Groupware Software). Affected is an unknown code block. The manipulation with an unknown input leads to a path traversal vulnerability. CWE is classifying the issue as CWE-22. The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory. This is going to have an impact on confidentiality. CVE summarizes:
Directory traversal vulnerability in the download feature in Cybozu Garoon 2.x through 2.5.4 and 3.x through 3.7 SP3 allows remote authenticated users to read arbitrary files via unspecified vectors.
The weakness was released 02/26/2014 (Website). The advisory is shared for download at support.cybozu.com. This vulnerability is traded as CVE-2014-0820 since 01/06/2014. The exploitability is told to be easy. It is possible to launch the attack remotely. The requirement for exploitation is a authentication. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1006.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 65815†). Entries connected to this vulnerability are available at VDB-66457 and VDB-66455. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
- 2.0.0
- 2.0.1
- 2.0.2
- 2.0.3
- 2.0.4
- 2.0.5
- 2.0.6
- 2.1
- 2.1.0
- 2.1.1
- 2.1.2
- 2.1.3
- 2.5
- 2.5.0
- 2.5.1
- 2.5.2
- 2.5.3
- 2.5.4
- 3.0
- 3.1
- 3.5
- 3.5.3
- 3.7
License
Website
- Vendor: https://cybozu-global.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Path traversalCWE: CWE-22
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/06/2014 🔍02/26/2014 🔍
02/26/2014 🔍
02/26/2014 🔍
03/24/2015 🔍
04/12/2025 🔍
Sources
Vendor: cybozu-global.comAdvisory: support.cybozu.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2014-0820 (🔍)
GCVE (CVE): GCVE-0-2014-0820
GCVE (VulDB): GCVE-100-66456
SecurityFocus: 65815 - Cybozu Garoon CVE-2014-0820 Directory Traversal Vulnerability
See also: 🔍
Entry
Created: 03/24/2015 15:54Updated: 04/12/2025 16:30
Changes: 03/24/2015 15:54 (47), 03/07/2019 10:00 (5), 04/12/2025 16:30 (17)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.